HomeHNSA • STO
Follow
Hansa Biopharma AB
Previous close
kr 28.36
Day range
kr 28.26 - kr 28.98
Year range
kr 20.14 - kr 58.10
Market cap
1.50B SEK
Avg Volume
104.74K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 50.41M | 63.85% |
Operating expense | 207.83M | 29.89% |
Net income | -124.46M | 16.29% |
Net profit margin | -246.89 | 48.91% |
Earnings per share | -2.36 | 26.02% |
EBITDA | -174.94M | -31.36% |
Effective tax rate | -0.17% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 732.06M | -51.07% |
Total assets | 1.02B | -39.67% |
Total liabilities | 1.19B | 9.35% |
Total equity | -167.88M | — |
Shares outstanding | 52.67M | — |
Price to book | -8.89 | — |
Return on assets | -40.09% | — |
Return on capital | -56.03% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -124.46M | 16.29% |
Cash from operations | -172.94M | -57.08% |
Cash from investing | 405.00K | 112.69% |
Cash from financing | -2.20M | -100.56% |
Net change in cash | -176.12M | -162.70% |
Free cash flow | -92.61M | -247.82% |
About
Founded
2007
Website
Employees
168